{Reference Type}: Journal Article
{Title}: 13C15N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans.
{Author}: Renuse S;Benson LM;Vanderboom PM;Ruchi FNU;Yadav YR;Johnson KL;Brown BC;Peterson JA;Basu R;McCormick DJ;Pandey A;Basu A;
{Journal}: Clin Proteomics
{Volume}: 19
{Issue}: 1
{Year}: May 2022 19
{Factor}: 5
{DOI}: 10.1186/s12014-022-09344-2
{Abstract}: <B>BACKGROUND: </B>Glucagon serves as an important regulatory hormone for regulating blood glucose concentration with tight feedback control exerted by insulin and glucose. There are critical gaps in our understanding of glucagon kinetics, pancreatic α cell function and intra-islet feedback network that are disrupted in type 1 diabetes. This is important for translational research applications of evolving dual-hormone (insulin + glucagon) closed-loop artificial pancreas algorithms and their usage in type 1 diabetes. Thus, it is important to accurately measure glucagon kinetics in vivo and to develop robust models of glucose-insulin-glucagon interplay that could inform next generation of artificial pancreas algorithms.<BR><B>METHODS: </B>Here, we describe the administration of novel 13C15N heavy isotope-containing glucagon tracers-FF glucagon [(Phe 6 13C9,15N; Phe 22 13C9,15N)] and FFLA glucagon [(Phe 6 13C9,15N; Phe 22 13C9,15N; Leu 14 13C6,15N; Ala 19 13C3)] followed by anti-glucagon antibody-based enrichment and LC-MS/MS based-targeted assays using high-resolution mass spectrometry to determine levels of infused glucagon in plasma samples. The optimized assay results were applied for measurement of glucagon turnover in subjects with and without type 1 diabetes infused with isotopically labeled glucagon tracers.<BR><B>RESULTS: </B>The limit of quantitation was found to be 1.56 pg/ml using stable isotope-labeled glucagon as an internal standard. Intra and inter-assay variability was < 6% and < 16%, respectively, for FF glucagon while it was < 5% and < 23%, respectively, for FFLA glucagon. Further, we carried out a novel isotope dilution technique using glucagon tracers for studying glucagon kinetics in type 1 diabetes.<BR><B>CONCLUSIONS: </B>The methods described in this study for simultaneous detection and quantitation of glucagon tracers have clinical utility for investigating glucagon kinetics in vivo in humans.